vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and SOUTH PLAINS FINANCIAL, INC. (SPFI). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $54.1M, roughly 1.5× SOUTH PLAINS FINANCIAL, INC.). SOUTH PLAINS FINANCIAL, INC. runs the higher net margin — 26.9% vs -38.1%, a 64.9% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 5.6%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Ally Financial Inc. is an American bank holding company incorporated in Delaware and headquartered at Ally Detroit Center in Detroit, Michigan. The company provides financial services including car finance, online banking via a direct bank, corporate lending, vehicle insurance, mortgage loans, and other related financing services such as installment sale and lease agreements.

PRCT vs SPFI — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.5× larger
PRCT
$83.1M
$54.1M
SPFI
Higher net margin
SPFI
SPFI
64.9% more per $
SPFI
26.9%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
5.6%
SPFI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
PRCT
PRCT
SPFI
SPFI
Revenue
$83.1M
$54.1M
Net Profit
$-31.6M
$14.5M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
-38.1%
26.9%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
18.3%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SPFI
SPFI
Q1 26
$83.1M
$54.1M
Q4 25
$76.4M
$53.9M
Q3 25
$83.3M
$54.2M
Q2 25
$79.2M
$54.7M
Q1 25
$69.2M
$49.2M
Q4 24
$68.2M
$51.9M
Q3 24
$58.4M
$47.9M
Q2 24
$53.4M
$48.6M
Net Profit
PRCT
PRCT
SPFI
SPFI
Q1 26
$-31.6M
$14.5M
Q4 25
$-29.8M
Q3 25
$-21.4M
$16.3M
Q2 25
$-19.6M
$14.6M
Q1 25
$-24.7M
$12.3M
Q4 24
$-18.9M
Q3 24
$-21.0M
$11.2M
Q2 24
$-25.6M
$11.1M
Gross Margin
PRCT
PRCT
SPFI
SPFI
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
SPFI
SPFI
Q1 26
-4.1%
Q4 25
-40.6%
35.4%
Q3 25
-27.8%
38.1%
Q2 25
-28.0%
34.1%
Q1 25
-39.7%
31.9%
Q4 24
-28.9%
39.9%
Q3 24
-38.4%
29.8%
Q2 24
-50.3%
29.3%
Net Margin
PRCT
PRCT
SPFI
SPFI
Q1 26
-38.1%
26.9%
Q4 25
-39.1%
Q3 25
-25.7%
30.1%
Q2 25
-24.7%
26.7%
Q1 25
-35.8%
25.0%
Q4 24
-27.6%
Q3 24
-35.9%
23.4%
Q2 24
-48.0%
22.9%
EPS (diluted)
PRCT
PRCT
SPFI
SPFI
Q1 26
$-0.56
Q4 25
$-0.54
$0.90
Q3 25
$-0.38
$0.96
Q2 25
$-0.35
$0.86
Q1 25
$-0.45
$0.72
Q4 24
$-0.34
$0.96
Q3 24
$-0.40
$0.66
Q2 24
$-0.50
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SPFI
SPFI
Cash + ST InvestmentsLiquidity on hand
$245.6M
$722.0M
Total DebtLower is stronger
$51.7M
$3.0K
Stockholders' EquityBook value
$347.7M
$504.9M
Total Assets
$487.1M
$4.6B
Debt / EquityLower = less leverage
0.15×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SPFI
SPFI
Q1 26
$245.6M
$722.0M
Q4 25
$286.5M
$552.4M
Q3 25
$294.3M
$635.0M
Q2 25
$302.7M
$470.5M
Q1 25
$316.2M
$536.3M
Q4 24
$333.7M
$359.1M
Q3 24
$196.8M
$471.2M
Q2 24
$214.1M
$298.0M
Total Debt
PRCT
PRCT
SPFI
SPFI
Q1 26
$51.7M
$3.0K
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
SPFI
SPFI
Q1 26
$347.7M
$504.9M
Q4 25
$365.9M
$493.8M
Q3 25
$380.3M
$477.8M
Q2 25
$385.8M
$454.1M
Q1 25
$389.2M
$443.7M
Q4 24
$402.2M
$438.9M
Q3 24
$241.2M
$443.1M
Q2 24
$251.8M
$418.0M
Total Assets
PRCT
PRCT
SPFI
SPFI
Q1 26
$487.1M
$4.6B
Q4 25
$508.1M
$4.5B
Q3 25
$511.5M
$4.5B
Q2 25
$513.1M
$4.4B
Q1 25
$519.4M
$4.4B
Q4 24
$534.0M
$4.2B
Q3 24
$374.1M
$4.3B
Q2 24
$374.4M
$4.2B
Debt / Equity
PRCT
PRCT
SPFI
SPFI
Q1 26
0.15×
0.00×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

SPFI
SPFI

Net Interest Income$42.9M79%
Noninterest Income$11.3M21%

Related Comparisons